Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000342·JANUS HENDERSON GROUP PLC
Schedule 13G ownership disclosure
Palisade Bio, Inc.
Common Stock · CUSIP: 696389402
Event date: 2025-11-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 14,885,421 · Class: 9.99%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 8,897,507 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000342
- Form type
- SCHEDULE 13G
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Dec 08, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership